biostudies-literatureUnknown64(1)Zimmermann RRobert Koch-Institut<h4>Background</h4>In 2016, the World Health Organization (WHO) released a strategy to eliminate hepatitis B, C, and D and defined indicators to monitor the progress. The Robert Koch Institute organized an interdisciplinary working meeting in 2019 to identify data sources and gaps.<h4>Objectives</h4>The objectives were to network, to create an overview of the data sources available in Germany on hepatitis B and C, and to discuss how to construct indicators.<h4>Materials and methods</h4>We extracted the WHO indicators relevant for Germany and determined how they can be constructed on the basis of available data. Stakeholders from public health services, clinics, laboratories, health insurance companies, research institutes, data holders, and registries attended a workshop and discussed methBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz77-90https://www.ebi.ac.uk/biostudies/studies/S-EPMC7772161biostudies-literature[How to assess the elimination of viral hepatitis B, C, and D in Germany? Outcomes of an interdisciplinary workshop].PMC7772161Kremer Kvan Bommel FSchmidt CMijocevic HKarcher HSchmidt DGillesberg Lassen STimm JMarcus Uvon Berenberg-Gossler PDiercke MOtt JJSarrazin CLohse TGerlich MWalker JKollan CBremer Vdie Hepatitis-Monitoring-ArbeitsgruppeZimmermann RMurajda LKulper-Schiek WBock CTFriesen JCiesek SOffergeld RSteffen GTacke FGlebe DPreußel KObermeier MKautz ATiemann CMaasoumy BSchlaud MCharles TKraywinkel KHeyne RKroll LEWedemeyer HHamouda OHarder TScholz SKoppe USantos-Hovener CSelb RMMahanty BDudareva SSchafberger ASchulte BHofmann AKantwerk Cfalse[How to assess the elimination of viral hepatitis B, C, and D in Germany? Outcomes of an interdisciplinary workshop].<h4>Background</h4>In 2016, the World Health Organization (WHO) released a strategy to eliminate hepatitis B, C, and D and defined indicators to monitor the progress. The Robert Koch Institute organized an interdisciplinary working meeting in 2019 to identify data sources and gaps.<h4>Objectives</h4>The objectives were to network, to create an overview of the data sources available in Germany on hepatitis B and C, and to discuss how to construct indicators.<h4>Materials and methods</h4>We extracted the WHO indicators relevant for Germany and determined how they can be constructed on the basis of available data. Stakeholders from public health services, clinics, laboratories, health insurance companies, research institutes, data holders, and registries attended a workshop and discussed meth2021-01-01T00:00:00Z2021 Jan2025-04-26T13:33:38.471Z2021-02-20T18:00:47ZS-EPMC77721613332605110.1007/s00103-020-03260-2